Pathstone Holdings’s Veracyte VCYT Stock Holding History

Pathstone Holdings’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-8,992	Closed	-$309K	–	2399
2025 Q3	$309K	Buy	+8,992	New	+$258K	﹤0.01%	2019

Other funds holding VCYT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Pathstone Holdings's VCYT Position: Q4 2025 in Review

Pathstone Holdings sold out of Veracyte (VCYT) in Q4 2025, closing a stake of 8,992 shares — an estimated $309K sold.

Pathstone Holdings first reported a position in VCYT in Q3 2025 and held it in 1 quarter. The position peaked at $309K in Q3 2025. 329 funds tracked by Wall St. Rank hold VCYT as of Q4 2025.

Pathstone Holdings reported no remaining Veracyte position as of Q4 2025 after selling out during the quarter.
Pathstone Holdings sold 8,992 Veracyte shares in Q4 2025, an estimated $309K.
Pathstone Holdings first reported a position in Veracyte in Q3 2025 and held it in 1 quarter.
Pathstone Holdings's Veracyte position peaked at $309K in Q3 2025.
329 funds tracked by Wall St. Rank held Veracyte as of Q4 2025.

Based on Pathstone Holdings's 13F filing for Q4 2025, filed 13 Feb 2026.